Department of Anaesthesia, Critical Care Medicine and Pain Therapy, University of Frankfurt, Frankfurt, Germany.
Division of Neurophysiology in the Center of Rare Diseases, Ulm University, Ulm, Germany.
J Physiol. 2019 Jan;597(1):225-235. doi: 10.1113/JP276528. Epub 2018 Nov 20.
During myotonia congenita, reduced chloride (Cl ) conductance results in impaired muscle relaxation and increased muscle stiffness after forceful voluntary contraction. Repetitive contraction of myotonic muscle decreases or even abolishes myotonic muscle stiffness, a phenomenon called 'warm up'. Pharmacological inhibition of low Cl channels by anthracene-9-carboxylic acid in muscle from mice and ADR ('arrested development of righting response') muscle from mice showed a relaxation deficit under physiological conditions compared to wild-type muscle. At increased osmolarity up to 400 mosmol L , the relaxation deficit of myotonic muscle almost reached that of control muscle. These effects were mediated by the cation and anion cotransporter, NKCC1, and anti-myotonic effects of hypertonicity were at least partly antagonized by the application of bumetanide.
Low chloride-conductance myotonia is caused by mutations in the skeletal muscle chloride (Cl ) channel gene type 1 (CLCN1). Reduced Cl conductance of the mutated channels results in impaired muscle relaxation and increased muscle stiffness after forceful voluntary contraction. Exercise decreases muscle stiffness, a phenomena called 'warm up'. To gain further insight into the patho-mechanism of impaired muscle stiffness and the warm-up phenomenon, we characterized the effects of increased osmolarity on myotonic function. Functional force and membrane potential measurements were performed on muscle specimens of ADR ('arrested development of righting response') mice (an animal model for low gCl conductance myotonia) and pharmacologically-induced myotonia. Specimens were exposed to solutions of increasing osmolarity at the same time as force and membrane potentials were monitored. In the second set of experiments, ADR muscle and pharmacologically-induced myotonic muscle were exposed to an antagonist of NKCC1. Upon osmotic stress, ADR muscle was depolarized to a lesser extent than control wild-type muscle. High osmolarity diminished myotonia and facilitated the warm-up phenomenon as depicted by a faster muscle relaxation time (T ). Osmotic stress primarily resulted in the activation of the NKCC1. The inhibition of NKCC1 with bumetanide prevented the depolarization and reversed the anti-myotonic effect of high osmolarity. Increased osmolarity decreased signs of myotonia and facilitated the warm-up phenomenon in different in vitro models of myotonia. Activation of NKCC1 activity promotes warm-up and reduces the number of contractions required to achieve normal relaxation kinetics.
在先天性肌强直中,氯离子(Cl-)电导降低导致强力自愿收缩后肌肉松弛受损和肌肉僵硬增加。强直性肌肉的重复收缩会减少甚至消除强直性肌肉僵硬,这一现象称为“热身”。用蒽-9-羧酸在来自小鼠的肌肉和 ADR(“纠正反应发育受阻”)肌肉中抑制低 Cl 通道,与野生型肌肉相比,在生理条件下显示出弛豫缺陷。在增加至 400mosmol/L 的渗透压下,强直性肌肉的弛豫缺陷几乎达到对照肌肉的水平。这些效应是通过阳离子和阴离子共转运蛋白 NKCC1 介导的,高渗性的抗强直性效应至少部分被布美他尼的应用拮抗。
低氯离子电导性肌强直是由骨骼肌氯离子(Cl-)通道基因 1(CLCN1)的突变引起的。突变通道的 Cl-电导降低导致强力自愿收缩后肌肉松弛受损和肌肉僵硬增加。运动减少肌肉僵硬,这一现象称为“热身”。为了进一步深入了解肌肉僵硬受损和热身现象的病理机制,我们研究了增加渗透压对强直性功能的影响。在 ADR(“纠正反应发育受阻”)小鼠(低 gCl 电导性肌强直的动物模型)和药理学诱导的强直性肌肉的肌肉标本上进行了功能力和膜电位测量。在监测力和膜电位的同时,将标本暴露于渗透压逐渐增加的溶液中。在第二组实验中,将 ADR 肌肉和药理学诱导的强直性肌肉暴露于 NKCC1 的拮抗剂中。在渗透压应激下,ADR 肌肉的去极化程度小于对照野生型肌肉。高渗透压减弱了强直性并促进了热身现象,表现为肌肉松弛时间(T)更快。渗透压应激主要导致 NKCC1 的激活。用布美他尼抑制 NKCC1 可防止去极化并逆转高渗透压的抗强直性效应。在不同的强直性肌体外模型中,增加渗透压可减少强直性并促进热身现象。NKCC1 活性的激活促进了热身并减少了达到正常弛豫动力学所需的收缩次数。